Between 2013 and 2023, the Hormones in Dosage Except Contraceptives and Antibiotics market in Portugal experienced fluctuations, growing from $178.74 million to $246.12 million. The market showed a steady upward trend until 2021, with notable year-on-year increases such as 18.6% in 2014 and 6.17% in 2021. However, the years 2022 and 2023 saw a decline and only a slight recovery respectively, with a CAGR of 1.35% over the last five years, indicating moderate growth overall.

Future trends to watch for:

Potential recovery from recent declines due to advancements in medical treatments.
Increased demand driven by aging population and prevalence of hormone-related conditions.
Regulatory and healthcare policy changes affecting market dynamics.